arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

IQVIA Holdings, Inc.

IQV Health Care Biotechnology: Commercial Physical & Biological Resarch
$278.32
▲ +3.9% Today
as of Oct 22, 16:49 ET
Last 30 days +4.76% Sep 14 → Oct 22
$256.49 $262.35 $268.21 $274.08 $279.94 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$274.99
High
$282.98
Low
$273.80
Volume
$2M
Avg Vol
$2M
Mkt Cap
$42.5B
P/E (TTM)
52.54
Beta
—
52w High
$282.98
52w Low
$154.50
Div Yield
—
Shares Out
$167M

Recent Press Releases & News last 60 days · 25 items

lean bull ▲ 6 ● 19 ▼ 0
Oct 22 · 12:58 EARNINGS Zacks neutral
IQVIA Gears Up to Post Q3 Earnings: Here's What Investors Should Know
Oct 20 · 13:00 RATING Zacks neutral
IQVIA Holdings (IQV) Earnings Expected to Grow: Should You Buy?
Oct 19 · 09:55 MT Newswires neutral
BMO Capital Adjusts Price Target on IQVIA to $305 From $270
▸ Show all 25 press releases & news Free account →

IQV earnings at a glance

IQVIA Holdings, Inc. (IQV) is scheduled to report earnings on Tuesday, October 27, 2026 before the market opens — in 4 days. Analysts expect earnings per share of $2.95, compared with $2.73 in the same quarter last year (+8%). The options market is pricing a move of about ±4.1% after the report, a range of roughly $267.03 to $289.61 from today's $278.32. Over its last 6 reports the stock rose the next day 4 times and fell 2, moving ±9.4% on average; after the most recent report on Jul 28, 2026 it moved +13.9%. That means options currently expect less movement than IQV has typically delivered. IQV beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 34%. The share price of $278.32 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$154
$283
96% of range
Avg surprise (last 6)
+2.1%
Avg reaction (last 6)
+4.5%
67% positive
Latest IV / EM
34%
EM ±4.1% · $260 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.53$1.96$2.39$2.81$3.24 Actual $1.53Actual $1.59Actual $1.63Actual $1.56Actual $1.97Actual $1.55Actual $2.37Est $2.38Actual $2.53Est $2.50Actual $2.73Est $2.68Actual $3.24Est $3.13Actual $2.64Est $2.51Actual $2.75Est $2.72 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$0$1.1B$2.2B$3.3B$4.4B Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jul 28, 2026Jun/2026 $2.75 $2.72 +1.1% +7.5% +13.9% earnings
Tue May 5, 2026Mar/2026 $2.64 $2.51 +5.2% +11.4% +9.6% earnings
Thu Feb 5, 20268K 2026-02-05 $3.24 $3.13 +3.5% — -10.7% earnings
Tue Oct 28, 2025Sep/2025 $2.73 $2.68 +1.9% — +0.3% earnings
Tue Jul 22, 2025Jun/2025 $2.53 $2.50 +1.2% — +17.9% earnings
Tue May 6, 2025Mar/2025 $2.37 $2.38 -0.4% — -4.0% earnings
Mon Sep 30, 2024Sep 2024 $1.55 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.97 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.56 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.63 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.59 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.53 — — — — financials
Fri Sep 30, 2022Sep 2022 $1.49 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Tue Oct 27, 2026Sep/2026BMO $2.95$2.73 +8.1%

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$4.15B—$4.10B$4.02B$3.83B—$3.90B$3.81B
Cost of revenue————————
Gross profit——————$915M$863M
Operating income$514M—$553M$506M$496M—$550M$520M
Net income$274M—$331M$266M$249M—$285M$363M
EPS (diluted)$1.61—$1.93$1.54$1.40—$1.55$1.97

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$1.95B$1.98B$1.81B$2.04B$1.74B$1.70B$1.57B$1.54B
Inventory————————
Total current assets$6.22B$6.25B$5.98B$6.34B$5.91B$5.83B$5.63B$5.62B
Total assets$29.68B$29.94B$28.73B$28.63B$27.32B$26.90B$27.18B$26.40B
Long-term debt$13.99B$13.88B$12.79B$14.18B$13.11B$12.84B$12.29B$12.09B
Total liabilities$23.33B$23.31B$22.44B$22.85B$21.34B$20.83B$20.21B$19.68B
Total equity$6.22B$6.50B$6.16B$5.79B$5.99B$6.07B$6.97B$6.71B

Implied volatility — last 90 days

30%37%45%52%60% Jun 07 — IV 52% · EM ±7.1%Jun 08 — IV 46% · EM ±6.0%Jun 09 — IV 43% · EM ±5.3%Jun 10 — IV 48% · EM ±5.7%Jun 11 — IV 48% · EM ±5.3%Jun 12 — IV 42% · EM ±4.3%Jun 15 — IV 59% · EM ±4.3%Jun 16 — IV 54% · EM ±3.2%Jun 17 — IV 57% · EM ±2.4%Jun 19 — IV 41% · EM ±9.1%Jun 22 — IV 42% · EM ±8.7%Jun 23 — IV 42% · EM ±8.6%Jun 24 — IV 42% · EM ±8.5%Jun 25 — IV 40% · EM ±7.9%Jun 26 — IV 43% · EM ±8.2%Jun 29 — IV 43% · EM ±7.6%Jun 30 — IV 42% · EM ±7.2%Jul 01 — IV 42% · EM ±7.0%Jul 02 — IV 42% · EM ±6.8%Jul 03 — IV 44% · EM ±6.8%Jul 06 — IV 45% · EM ±6.3%Jul 07 — IV 43% · EM ±5.7%Jul 08 — IV 43% · EM ±5.4%Jul 09 — IV 40% · EM ±4.7%Jul 10 — IV 37% · EM ±4.1%Jul 13 — IV 47% · EM ±3.9%Jul 14 — IV 50% · EM ±3.6%Jul 15 — IV 60% · EM ±3.6%Jul 16 — IV 47% · EM ±2.0%Jul 20 — IV 49% · EM ±11.5%Jul 21 — IV 48% · EM ±11.1%Jul 22 — IV 46% · EM ±10.5%Jul 23 — IV 48% · EM ±10.9%Jul 24 — IV 48% · EM ±10.6%Jul 27 — IV 53% · EM ±11.1%Jul 28 — IV 42% · EM ±8.5%Jul 29 — IV 39% · EM ±7.8%Jul 30 — IV 37% · EM ±7.3%Jul 31 — IV 38% · EM ±7.3%Aug 03 — IV 41% · EM ±7.3%Aug 04 — IV 39% · EM ±6.7%Aug 05 — IV 38% · EM ±6.4%Aug 06 — IV 39% · EM ±6.3%Aug 07 — IV 34% · EM ±5.4%Aug 10 — IV 37% · EM ±5.1%Aug 11 — IV 35% · EM ±4.6%Aug 12 — IV 37% · EM ±4.6%Aug 13 — IV 32% · EM ±3.7%Aug 14 — IV 34% · EM ±3.8%Aug 17 — IV 36% · EM ±3.0%Aug 18 — IV 36% · EM ±2.6%Aug 19 — IV 38% · EM ±2.2%Aug 20 — IV 53% · EM ±2.2%Aug 24 — IV 34% · EM ±7.1%Aug 25 — IV 33% · EM ±6.8%Aug 26 — IV 34% · EM ±6.8%Aug 27 — IV 32% · EM ±6.4%Aug 28 — IV 31% · EM ±5.9%Aug 31 — IV 32% · EM ±5.6%Sep 01 — IV 33% · EM ±5.7%Sep 02 — IV 34% · EM ±5.6%Sep 03 — IV 31% · EM ±5.1%Sep 04 — IV 33% · EM ±5.2%Sep 07 — IV 38% · EM ±5.2%Sep 08 — IV 35% · EM ±4.6%Sep 09 — IV 38% · EM ±4.8%Sep 10 — IV 35% · EM ±4.2%Sep 11 — IV 37% · EM ±4.1%Sep 14 — IV 44% · EM ±3.7%Sep 15 — IV 43% · EM ±3.1%Sep 16 — IV 42% · EM ±2.5%Sep 17 — IV 39% · EM ±1.6%Sep 21 — IV 34% · EM ±7.0%Sep 22 — IV 34% · EM ±7.0%Sep 23 — IV 31% · EM ±6.3%Sep 24 — IV 34% · EM ±6.6%Sep 25 — IV 32% · EM ±6.0%Sep 28 — IV 32% · EM ±5.7%Sep 29 — IV 33% · EM ±5.6%Sep 30 — IV 32% · EM ±5.3%Oct 01 — IV 30% · EM ±4.9%Oct 02 — IV 31% · EM ±4.9%Oct 06 — IV 34% · EM ±4.4%Oct 07 — IV 43% · EM ±5.4%Oct 08 — IV 34% · EM ±4.1%

Sector peers

INCY
Incyte Corporation
$23.0B $116.93+0.3%
MEDP
Medpace Holdings, Inc.
$16.9B $653.96+5.1%
CRL
Charles River Laboratories International, Inc.
$14.3B $339.66+7.7%
ICLR
ICON plc
$12.6B $185.43+6.5%
ABSI
Absci Corporation
$1.8B $9.37+3.3%
OABI
OmniAb, Inc.
$663M $4.78-3.6%

IQV earnings FAQ

When is IQV's next earnings date?

IQVIA Holdings, Inc. is expected to report on October 27, 2026, before the market opens.

What is IQV's expected move for earnings?

Options currently price a move of about ±4.1%, or $11.29 per share either way from $278.32.

How does IQV stock usually react to earnings?

Across the last 6 reports the average next-day move was ±9.4%, up 4 times and down 2 times.

What EPS are analysts expecting from IQVIA Holdings, Inc.?

The consensus estimate is $2.95 per share, versus $2.73 a year ago.

What is IQV's implied volatility?

IQV's at-the-money implied volatility is about 34% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in